Cargando…
Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504197/ https://www.ncbi.nlm.nih.gov/pubmed/28589404 http://dx.doi.org/10.1007/s12325-017-0563-2 |
_version_ | 1783249238288760832 |
---|---|
author | Adsit, Sandra Zaldivar, Enrique Rivas Sofen, Howard Dei-Cas, Ignacio Maldonado-García, César Peñaranda, Elkin O. Puig, Luís Meng, Xiangyi Fox, Todd Guana, Adriana |
author_facet | Adsit, Sandra Zaldivar, Enrique Rivas Sofen, Howard Dei-Cas, Ignacio Maldonado-García, César Peñaranda, Elkin O. Puig, Luís Meng, Xiangyi Fox, Todd Guana, Adriana |
author_sort | Adsit, Sandra |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5504197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-55041972017-07-25 Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials Adsit, Sandra Zaldivar, Enrique Rivas Sofen, Howard Dei-Cas, Ignacio Maldonado-García, César Peñaranda, Elkin O. Puig, Luís Meng, Xiangyi Fox, Todd Guana, Adriana Adv Ther Erratum Springer Healthcare 2017-06-06 2017 /pmc/articles/PMC5504197/ /pubmed/28589404 http://dx.doi.org/10.1007/s12325-017-0563-2 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Erratum Adsit, Sandra Zaldivar, Enrique Rivas Sofen, Howard Dei-Cas, Ignacio Maldonado-García, César Peñaranda, Elkin O. Puig, Luís Meng, Xiangyi Fox, Todd Guana, Adriana Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials |
title | Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials |
title_full | Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials |
title_fullStr | Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials |
title_full_unstemmed | Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials |
title_short | Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials |
title_sort | erratum to: secukinumab is efficacious and safe in hispanic patients with moderate-to-severe plaque psoriasis: pooled analysis of four phase 3 trials |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504197/ https://www.ncbi.nlm.nih.gov/pubmed/28589404 http://dx.doi.org/10.1007/s12325-017-0563-2 |
work_keys_str_mv | AT adsitsandra erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials AT zaldivarenriquerivas erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials AT sofenhoward erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials AT deicasignacio erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials AT maldonadogarciacesar erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials AT penarandaelkino erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials AT puigluis erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials AT mengxiangyi erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials AT foxtodd erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials AT guanaadriana erratumtosecukinumabisefficaciousandsafeinhispanicpatientswithmoderatetosevereplaquepsoriasispooledanalysisoffourphase3trials |